Found 1,117 investors
Gonzague Lefebvre
Lille, Nord-Pas-de-Calais, France
Gonzague Lefebvre - Co-Founder & CEO @ Visiotalent
Individual/Angel
Seed
Past Investments
SENCROP
Greg Getten
Santa Clara, California, United States
Venture Capital (AI - Drug Discovery & IoT)
Individual/Angel
Seed
Past Investments
Appetia Inc, Xudera Inc.
Hussein Kanji
London, England, United Kingdom
Hussein is a partner at Hoxton Ventures. He currently represents Hoxton on the boards of Biotx, Giraffe360, Kbox Global, Skin Analytics, SOC...
Investment Partner
Individual/Angel
Seed
Early Stage Venture
Series A
Past Investments
FINESSE, Giraffe360, Njini, LLUSTRE, bd4travel, SOC.OS, Campanja, Karakuri, Skin Analytics, Behavox, Yieldify, Baseimmune, TourRadar, Replan, OpenGamma, Signpost, Fy!, POPxo, Kitt, Algomi
Ian Prangley
London, England, United Kingdom
Ian is a highly respected sports physiotherapist and physical performance coach, having worked within the Australian Institute of Sport prog...
Individual/Angel
Seed
Past Investments
TrackActive
James Hardiman
San Francisco, California, United States
James has more than five years of experience advising both Fortune 50 and pre-revenue healthcare and biotech companies on their sales and ma...
Investment Partner
Individual/Angel
Series B
Past Investments
Semantic Health, nTopology, Subtle Medical, Sequence Bio
Javier de Echevarría
Madrid, Madrid, Spain
Serial entrepreneur highly experienced in the diagnostics, genetics and biotech industries. First having developed an entire diagnostics bus...
Individual/Angel
Past Investments
Veritas Intercontinental
Jenna Ciotti
Boston, Massachusetts
Healthcare Growth Equity Investor
Consumer Internet
Health & Hospital Services
Health IT
SaaS
Seed
Past Investments
Smartkargo, YAPI Dental Software, BeSmartee, Mize, Inc., Reebee
Jonathan Wolfson
San Francisco, California, United States
Jonathan Wolfson is Chief Executive Officer and co-founder of Solazyme. Solazyme is a leading industrial biotechnology company producing re...
Individual/Angel
Seed
Past Investments
Zently
Ken Powell
London, England, United Kingdom
Prior to his current role, Ken had very extensive experience of the Biotechnology sector. In reverse order he was: Executive Chairman of Q-C...
Individual/Angel
Seed
Past Investments
Q Chip
Kiran Mazumdar-Shaw
Bangalore, Karnataka, India
Kiran Mazumdar-Shaw is Chairperson and Managing Director of Biocon Limited, a biotechnology company based in Bangalore, India. Kiran is h...
Investment Partner
Individual/Angel
Seed
Past Investments
ThePrint, BUGWORKS Research, UE LifeSciences
Lutz Haase
Berlin, Berlin, Germany
Lutz Haase is the CEO of FTWK, a digital product company. We partner with brands like Bayer, Biotronik, Boehringer Ingelheim, Roché or Therm...
Individual/Angel
Past Investments
CardioCube (acquired by Voxel), Super Izzy AI
Marc Merrill
Los Angeles, California, United States
Marc Merrill Co-founded of Riot Games, Inc. in 2006 and serves as its President. Marc Merrill served as Chief Marketing Officer of Riot Game...
Individual/Angel
Seed
Pre-Seed
Past Investments
OZ, US, Anzu.io, PortalOne, Cloud Paper, Pipeline, Rally Cry, Fast Break Labs, Emerge, OpenBCI
Margarita Chavez
North Chicago, Illinois, United States
Margarita contributes more than 20 years of deal-making experience, including 10 years in biotech and pharma. Margarita has led and managed ...
Investment Partner
Past Investments
Paragen Bio, Carisma Therapeutics
Mark Edwards
Ireland
Mr. Patrick Joy is the Founder and Owner of Suretank Group. He serves as Board Member at Suretank Group. He serves as Chairman at VT IoT.
Individual/Angel
Seed
Early Stage Venture
Past Investments
Oculi, Viewmind
Max Gerbut
Reno, Nevada, United States
Inventor and entrepreneur in energy efficiency construction, smart-homes, IoT, 3D-printing. Professional in marketing, physics, engineeri...
Individual/Angel
Past Investments
haus.me
Michael Neril
United States
Mr. Milan Patel is a Co-Founder and serves as Chief Executive Officer and Board Member at PathogenDx. He also is an Angel Investor. Mr. Patel served as the Chief Financial Officer at GMSbiotech. He has over 20 years of experience with large public, to small private and entrepreneurial companies in numerous industries from automotive, technology and government technology services. For the past six years, he served as Chief Financial Officer of 2020 Company a leading premier professional services firm that delivered business and technology solutions to the government, in the areas of health, education, and science. Prior to that, Milan worked at Intel Corporation as a Senior Finance Manager in their Technology Manufacturing Group with hands on experience in manufacturing finance, direct and indirect procurement and construction negotiations and spending. Milan has extensive experience in corporate finance, mergers and acquisitions, business strategy and planning, infrastructure and organizational development, and controls, compliance and audit.
Individual/Angel
Seed
Past Investments
CopperEgg, Wavefront, Zanbato, Mailgun, HelloSign, AppLovin, Ionic Security, Bitnet Technologies, Luminate, TrueAccord, REscour, Zappli, Social Eyes, Meteor, Respondly, Appurify, Boomtown, Stuph, Badgeville, Localresponse, Okta, Boost Media, Bityota, Workspot, LiveLoop, Pindrop, CloudHelix, Alpha, PagerDuty, Vungle, StarMobile, Upstream Commerce, AeroFS by Redbooth, Voxer, Tasty Labs, Science Exchange, Indiegogo, Everwise, MongoHQ, DigitalGenius, GOAT Sneaker Marketplace, Sunglass, TapSense, Workast, Imubit, Libertadcard, Quixey, True Accord, Applifier, Hipmunk, Lockpath, yozio, Zuora, Cyble, CardSpring, Waycare, Epic, Panorama Education, Koality, TenXer, Nebula, WePay, Poynt, Chef, Pepperdata, Sparta Science, PureWave Networks, Rypple, RethinkDB, Keewi, TakeLessons, Turo
Michael Skok
United States
Mr. Michael Skok is the Co-Founder and serves as a Partner at Underscore VC. Mr. Skok started his first software business as a teenager, spent 21 years as an entrepreneur and then the past 18 years as a venture investor. During this time, he has founded, worked with and invested in startups, and created thousands of jobs and billions of dollars of value. Along the way, he also mentored and taught for 4 years at Harvard University, and created the Startup Secrets series. As an entrepreneur and an investor, Mr. Skok has focused on breakthrough technologies and disruptive business models including Open Source, Cloud, IoT, and emerging domains such as Blockchain, Virtual/Augmented Reality, and Artificial Intelligence/Machine Learning. He has served on or is active on many private and public boards such as Acquia, Demandware (now a Salesforce company), Mautic (acquired by Acquia in 2019), Salsify and Zaius. He has also participated in leadership roles in many industry groups such as the Software Publishers Association where he was Chairman for many years in Europe. In 2015, Mr. Skok co-founded Underscore VC first and foremost to empower entrepreneurs to realize their vision in building impactful businesses. He has a passion for helping the next generation of entrepreneurs succeed by not only investing but bringing the resources, talent and commitment of an aligned community around them to assure their success.
Individual/Angel
Seed
Past Investments
Acquia, Wis.dm, Lumigent Technologies, Unidesk, Moltin, Actifio, Zaius, Salsify, HelloTeam, Demandware, Cazena
Mitch Lasky
United States
Dr. William Radany serves as Angel Investor at E. William Radany. He is an Angel Investor. Dr. William Radany served as President and Chief Executive Officer at Verdezyne. He was a Board Member of xF Technologies. Prior to joining Verdezyne, he was the President and CEO of High Throughput Genomics, a provider of novel array-based gene expression assay technology for the life science industry. Previously, Dr. Radany was President of Biacore and founder and CEO of NeoGenex. Dr. Radany has held executive positions at Xencor, Caliper Technologies and Stratagene, where he helped establish business relationships with pharmaceutical and biotechnology companies. Dr. Radany received his Bachelor of Science degree in Cell Biology from Colorado State University and a Ph.D. in Biochemistry/Physiology from the University of Wyoming.
Individual/Angel
Series B
Series A
Past Investments
Manticore Games, Discord, Cyanogen, Thatgamecompany, PlayFab, Engine Yard, Outpost, Meteor Entertainment, PlayFab, Inc., CYNGN, Snap Inc., NaturalMotion, Red Robot Labs, Gaikai, Vivox, HipLogic
Mohammad Chowdhury
United Kingdom
Dr. Fintan Walton is the Founder and serves as Chief Executive Officer & Board Member at PharmaVentures. Over a period of three decades, Fintan has built PharmaVentures into a global player in supporting transactions for blue chip corporations and emerging innovator corporations. In that time, the firm has delivered more than 1,000 transaction related assignments for companies in 38 countries. Clients have included major pharmaceutical and biotechnology companies as well as diversified chemical corporations, medical device, generic and OTC companies. Its clients have also included major banks, investment/merchant banks, as well as private equity and venture capital groups. Dr Walton majored in Genetics at Trinity College Dublin, Ireland, where he also gained a Ph.D. Prior to his entrepreneurial activities at PharmaVentures, Fintan had built his R&D and commercial experience in biotechnology within management positions at Bass and Celltech plc (1982-1992). In 1996, he also founded PharmaDeals, the leading database and publishing business related to deal making data and analytics. Thousands of customers from around the world either bought or subscribed to these PharmaDeals publications. The PharmaDeals business was sold to IMS Health (now IQVIA) in Aug 2012.
Individual/Angel
Past Investments
GPM Investments, LAZ Karp
Naheed Kurji
Toronto, Ontario, Canada
Naheed Kurji is the President and CEO of Cyclica, a Toronto-based biotechnology company that leverages artificial intelligence and computati...
Individual/Angel
Past Investments
Cyclica
Showing 61 to
80 of
1,117 results